HESTERBIO.NS

Hester Biosciences Limited · Healthcare · Drug Manufacturers-Specialty & Generic

Earnings call summary →

—

Loading quote…

Highlights

Market Cap

$14.21B

PE Ratio

51.14985253697307

EV to Ebitda

27.14253787769983

Earnings Yield

161740454.75%

Revenue (TTM)

$30.4M

Net Income (TTM)

$3.6M

Revenue (Annual YoY Growth)

—

Revenue (Quarterly YoY Growth)

21.10%

Profit Margin

10.79%

Return on Equity

—

Debt to Equity Ratio

0.9886286181669469

Dividend Yield

0.00%

All fundamentals

Core6 fields›

Market Cap$14.21B

Revenue TTM$30.4M

Shares Outstanding8.5M

Float2482602

Insider Ownership63.35%

Institutional Ownership0.45%

Growth Estimates3 fields›

Revenue Growth (Quarterly YoY)21.10%

EPS Growth (Quarterly YoY)-40.60%

EPS Growth Est Quarterly0

Operations14 fields›

Revenue TTM$30.4M

Gross Margin TTM71.97%

Gross Margin (Quarterly)73.56%

Operating Margin TTM16.14%

Operating Margin (Quarterly)18.04%

Profit Margin TTM10.79%

Profit Margin (Quarterly)14.93%

Net Income TTM$3.6M

EPS TTM35.05

EBIT Margin TTM24.12%

EBITDA TTM$7.3M

Capex % of Revenue TTM63.39%

Capital Expenditures$19.3M

FCF % of Revenue (Quarterly)-34.56%

Efficiency1 fields›

ROA4.81%

Valuation10 fields›

P/E (TTM)51.14985253697307

P/E Forward0

EV/EBITDA (TTM)27.14253787769983

EV/Revenues (TTM)7.5614

EV/Revenues Forward7.817068479671708

EV/CFO7.817068479671708

Price To Book5.775576910377001

Earnings Yield161740454.75%

Dividend Yield0.00%

Payout Ratio28.53%

Liquidity6 fields›

Cash Per Share47.2712332921705

Current Ratio2.009979566141716

Total Assets$6237.91T

Shareholders Equity$2640.84T

Debt to Equity0.9886286181669469

Interest Expense$94.5M

Yields3 fields›

Dividend Yield0.00%

Payout Ratio28.53%

Earnings Yield161740454.75%